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Quantification of two isomeric flavones 
in rat colon tissue using reverse phase high 
performance liquid chromatography
Crystal L. Whitted1, Victoria E. Palau1, Ruben D. Torrenegra2, Oscar E. Rodriguez3 and Sam Harirforoosh1* 
Abstract 
Background: Antineoplastic activity has been previously shown for two isomeric flavones, 5,7-dihydroxy-3,6,8-
trimethoxy flavone (flavone A) and 3,5-dihydroxy-6,7,8-trimethoxy flavone (flavone B), against colon cancer cell lines 
(Thomas et al. in PLoS ONE 7:e39806, 5). Here, we present modified methods for the extraction and quantification of 
flavones A and B in rat colon tissue after intravenous dosing via high performance liquid chromatography, from the 
originally described procedure for extraction and quantification in rat plasma (Whitted et al. in J Chromatogr B Analyt 
Technol Biomed Life Sci 1001:150–155, 7).
Results: Modifications included tissue homogenization (1 g tissue: 2 mL water), filtration of the supernatant with a 
PVDF membrane, and the use of only one calibration curve to determine the concentration of each flavone in colon 
tissue. Good separation was achieved and representative equations were linear with r2 ≥ 0.99 for both flavones. Preci-
sion and accuracy for flavone A ranged from 0.88–24.03 and 109–116%. Precision and accuracy for flavone B ranged 
from 1.62–33.56 and 98–113%. Concentrations of 1639 ± 601 ng/g flavone A and 5975 ± 2480 ng/g of flavone B 
were detected in rat colon tissue 6 h post dosing.
Conclusions: Modifications to the extraction methods for flavone A and flavone B from rat colon tissue had good 
separation, precision, and accuracy.
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Background
Many flavonoids have been recognized for their anti-
tumor properties [1–4]. It is known that these activities 
are greatly determined by their chemical structure which 
subsequently dictates their ability to interact with cellular 
molecules [1]. This differential effect has been observed 
with flavone isomers 5,7-dihydroxy-3,6,8-trimethoxy 
flavone (flavone A) and 3,5-dihydroxy-6,7,8-trimethoxy 
flavone (flavone B) [5]. Specifically, each isomer has been 
shown to target colon cancer cells with distinct pheno-
typical characteristics via different mechanisms of action 
[6]. However, it is unknown whether either of these fla-
vones distribute to the colon after intravenous adminis-
tration of these compounds. Modifications were made 
to methods developed for extracting and quantifying 
these flavones in rat plasma [7] using reverse phase high 
performance liquid chromatography (HPLC). The mod-
ifications included preparation of the sample by homog-
enization in water, filtration using a polyvinylidene 
fluoride (PVDF) membrane, and the creation of a sin-
gle calibration curve to determine the concentration of 
either flavone in colon tissue.
These methods allowed for the detection of flavone A 
and flavone B in rat colon. Our data indicate that flavone 
B was found in higher concentrations in the colon than 
flavone A, which may be the result of higher volume of 
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distribution value of flavone B [7] compared to that of fla-
vone A.
Methods
Procedure to extract and purify flavones A and B
The compounds were obtained as described before [5]. 
Briefly, flavone A was purified from dried flowers of Gna-
phalium elegans extracted with chloroform using a silica 
gel chromatography column. Flavone B was purified 
from leaves of Achyrocline bogotensis, using chloroform, 
followed by crystallizations in hexane. The physical and 
spectroscopic properties of these compounds allowed 
their proper identification.
Stock solution and standards
Stock solutions of flavone A at a concentration of 100 µg/
mL, prepared as described previously [7], and 25 µg/mL 
celecoxib (Toronto Research Chemicals; Toronto, ON, 
CA) were prepared with acetonitrile/water/acetic acid/
triethylamine (60:40:0.2:0.05). Stock solutions of 100 µg/
mL of flavone B, prepared as described previously [7], 
and 25 µg/mL diclofenac (MP Biomedicals, LLC; Solon, 
OH) were prepared with acetonitrile/water/acetic acid/
trimethylamine (70:30:0.2:0.05). All stock solutions were 
stored protected from light at 4 °C. HPLC grade acetoni-
trile, acetic acid, trimethylamine, and water were pur-
chased from Fisher Scientific (Pittsburgh, PA). Flavone 
A or flavone B were mixed with polyethylene glycol 400 
(Electron Microscopy Sciences; Hatfield, PA) for intrave-
nous injection.
Sample preparation
Colon tissue was homogenized using a PowerGen 700 
from Fisher Scientific (Pittsburgh, PA) in a 1:2 ratio with 
water (1  mg/2  mL). Serial concentrations for calibra-
tion curves (flavone A: 250–100,000  ng/g and flavone 
B: 1000–25,000  ng/g) were prepared. Briefly, 100  μL of 
blank homogenate was spiked with 100  μL flavone, 100 
µL internal standard (25 µg/mL celecoxib or diclofenac), 
and 200 μL of organic solvent (acetonitrile). The samples 
were vortex mixed before being centrifuged for 15 min at 
3000×g. The supernatant was removed and filtered with 
a PDVF filter (0.45 µm) into a clean tube and evaporated 
using a Labconco vacuum concentrator (Kansas City, 
MO). Mobile phase (200 μL) was used to reconstitute the 
residue and 100 μL of sample was injected into the HPLC 
column. Analysis was conducted in triplicate.
HPLC conditions and quantitation
HPLC assays were performed using a Shimadzu liquid 
chromatography system (Shimadzu Scientific Instru-
ments Inc., Columbia, Maryland, USA) with an ACE C18 
(100  ×  4.6  mm) (Aberdeen, Scotland) column. Mobile 
phases used for HPLC contained acetonitrile/water 
60:40 (flavone A) and 70:30 (flavone B) with 0.2% acetic 
acid and 0.05% triethylamine. Detection wavelength was 
at 245  nm with a temperature of 30  °C. Flow rate was 
0.4  mL/min with run times of 11 and 10  min, respec-
tively. LC solutions program was used to collect and ana-
lyze the data.
Animals and drug administration
The methods described here were used to determine the 
concentrations of flavone A or flavone B in colon tissue 
collected from male Sprague–Dawley rats (Charles River 
Laboratories, Raleigh, NC, USA) used in a previous study 
[7]. Briefly, flavones were mixed in polyethylene glycol 
400 and were administered by intravenous injection to 
deliver a 20 mg/kg dose of flavone A (n = 6) or flavone 
B (n = 6). Animals were euthanized under anesthesia 6 h 
post dosing. Colon tissue was collected and flash frozen 
using dry ice and stored at −80 °C until analyzed for the 
measurement of concentrations of flavones.
Results
Good separation was achieved (Figs.  1, 2) and the peak 
area ratios of flavone against internal standard were 
plotted in Excel to make the calibration curves (Fig.  3). 
Representative equation for flavone A concentra-
tions 250–100,000  ng/g was y  =  2E  −  05x  +  0.0029 
and flavone B concentrations 1000–25,000  ng/g was 
y = 7E − 05x + 0.0531 with r2 ≥ 0.99. Three calibration 
curves were used to determine the precision (coefficient 
of variation—CV) and accuracy of the methods. Data 
is presented as mean  ±  standard deviation (Tables  1, 
2). Analysis yielded 1639  ±  601  ng/g of flavone A and 
5975 ± 2480 ng/g of flavone B in colon tissue (Fig. 4).
Conclusion
Modifications to the methods developed for extrac-
tion and quantification of flavone A and flavone B from 
rat colon tissue yield good separation, precision, and 
accuracy. The distribution of both flavones to the colon 
suggests that they would be good candidates for in vivo 
antitumor studies for colon cancer.
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Fig. 1 Elution of flavone A from colon. HPLC chromatographs of a blank colon; b colon spiked with internal standard (celecoxib 25 µg/mL); c colon 
spiked with flavone A (100 µg/mL) and internal standard
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Fig. 2 Elution of flavone B from colon. HPLC chromatographs of a blank colon; b colon spiked with internal standard (diclofenac 25 µg/mL); c colon 
spiked with flavone B (100 µg/mL) and internal standard
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Fig. 3 Calibration curves were made by graphing the ratio of flavone/internal standard area under the curve extracted from colon tissue versus the 
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Table 1 Precision and  accuracy for  250–100,000  ng/g fla-
vone A extracted from rat colon tissue
Concentration 
(ng/g)
Error (%) Observed 
(n = 3)
CV Accuracy (%)
100,000 13.88 ± 2.14 113,888 ± 2138 1.87 114
25,000 16.32 ± 1.06 29,081 ± 265 0.91 116
10,000 11.83 ± 4.15 11,182 ± 415 3.71 111
5000 9.93 ± 0.97 5496 ± 48 0.88 109
2500 13.92 ± 4.87 2848 ± 121 4.27 113
1000 11.45 ± 8.90 1114 ± 89 7.98 111
500 16.65 ± 21.51 558 ± 129 23.21 111
250 21.02 ± 19.30 285 ± 68 24.03 113
Table 2 Precision and  accuracy for  1000–25,000  ng/g fla-
vone B extracted from rat colon tissue
Concentration 
(ng/g)
Error (%) Observed 
(n = 3)
CV Accuracy (%)
25,000 1.51 ± 0.50 25,204 ± 410 1.62 101
10,000 2.89 ± 0.52 10,075 ± 345 3.43 101
5000 3.69 ± 3.42 4934 ± 271 5.51 98
2500 4.22 ± 2.55 2480 ± 142 5.73 99
1000 25.18 ± 27.00 1128 ± 378 33.56 113
Fig. 4 Distribution of flavones to target tissue. Male Sprague–Dawley 
rats received 20 mg/kg of either flavone A or flavone B via intrave-
nous injection. The colon tissues were collected 6 h after dosing and 
analyzed for the presence of flavone using a HPLC system
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